CA1336913C - Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase - Google Patents

Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase

Info

Publication number
CA1336913C
CA1336913C CA000557467A CA557467A CA1336913C CA 1336913 C CA1336913 C CA 1336913C CA 000557467 A CA000557467 A CA 000557467A CA 557467 A CA557467 A CA 557467A CA 1336913 C CA1336913 C CA 1336913C
Authority
CA
Canada
Prior art keywords
trimethoxyphenyl
dimethyl
cholesterol
carbon atoms
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000557467A
Other languages
English (en)
French (fr)
Inventor
Milton Louis Hoefle
Bruce David Roth
Ann Holmes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of CA1336913C publication Critical patent/CA1336913C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
CA000557467A 1987-02-24 1988-01-27 Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase Expired - Fee Related CA1336913C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/017,960 US4716175A (en) 1987-02-24 1987-02-24 Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
US017,960 1987-02-24

Publications (1)

Publication Number Publication Date
CA1336913C true CA1336913C (en) 1995-09-05

Family

ID=21785503

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000557467A Expired - Fee Related CA1336913C (en) 1987-02-24 1988-01-27 Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase

Country Status (17)

Country Link
US (1) US4716175A (OSRAM)
EP (1) EP0283742B1 (OSRAM)
JP (1) JPH07121895B2 (OSRAM)
KR (1) KR880009933A (OSRAM)
AT (1) ATE89814T1 (OSRAM)
CA (1) CA1336913C (OSRAM)
DE (1) DE3881249T2 (OSRAM)
DK (1) DK165406C (OSRAM)
ES (1) ES2056843T3 (OSRAM)
FI (1) FI89593C (OSRAM)
HK (1) HK148195A (OSRAM)
IE (1) IE59998B1 (OSRAM)
MX (1) MX9203139A (OSRAM)
NO (1) NO174043C (OSRAM)
NZ (1) NZ223410A (OSRAM)
PT (1) PT86811B (OSRAM)
ZA (1) ZA88604B (OSRAM)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
GB8827152D0 (en) * 1988-11-21 1988-12-29 Wellcome Found Anti-atherosclerotic diaryl compounds
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
WO1991004027A1 (en) * 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
AU6659090A (en) * 1989-11-16 1991-06-13 Warner-Lambert Company Acat inhibitors
WO1991015464A1 (en) * 1990-04-11 1991-10-17 Warner-Lambert Company Amide ester acat inhibitors
US5149709A (en) * 1990-07-03 1992-09-22 Schering Corporation Inhibitors of acyl-coenzyme A: cholesterol acyl transferase
AU650036B2 (en) * 1990-07-25 1994-06-09 Teijin Limited Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
DK0559898T3 (da) * 1990-11-26 1996-08-19 Taisho Pharmaceutical Co Ltd Anilidderivater
FR2673625B1 (fr) * 1991-03-08 1993-05-07 Adir Nouveaux derives d'acylaminophenol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5420164A (en) * 1991-04-04 1995-05-30 Yoshitomi Pharmaceutical Industries, Ltd. Cycloalkylurea compounds
EP0619312A4 (en) * 1991-12-25 1995-07-19 Taisho Pharmaceutical Co Ltd ANILIDE DERIVATIVES.
CA2134359C (en) * 1992-05-28 1997-07-01 Ernest S. Hamanaka New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
HUT67475A (en) * 1992-07-20 1995-04-28 Eisai Co Ltd Benzene derivatives and pharmaceutical compositions containing them as active components
US5321031A (en) * 1992-09-23 1994-06-14 Schering Corporation 1,2-disubstituted ethyl amides as inhibitors of ACAT
CA2107196A1 (en) * 1992-09-29 1994-03-30 Mitsubishi Chemical Corporation Carboxamide derivatives
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
AU672699B2 (en) * 1993-06-30 1996-10-10 Sankyo Company Limited Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5596001A (en) * 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
IT1265209B1 (it) * 1993-11-22 1996-10-31 Pierrel Spa Difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro
US6133326A (en) * 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
DE69600396T2 (de) * 1995-02-08 1998-10-29 Nippon Shoji Kaisha Ltd Anilinderivate, die einen mehrfach ungesättigten Fettsäurerest tragen und ihre Anwendung
DZ3288A1 (en) 2000-02-02 2001-08-09 Warner Lambert Co Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders
IL146531A0 (en) * 2000-03-16 2002-07-25 Neurogen Corp 5-substituted arylpyrimidines
US20040072903A1 (en) * 2001-05-08 2004-04-15 Auerbach Bruce Jeffrey Carboxyalkylether-acat inhibitors combinations
EP1281399A3 (en) * 2001-08-01 2004-02-11 Warner-Lambert Company Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
DK1725234T4 (en) 2004-03-05 2016-05-09 Univ Pennsylvania METHODS OF TREATING DISEASES OR DISEASES CONNECTED WITH HYPERLIPIDEMIA AND HYPERCOLESTEROLYMIA WITH MINIMIZATION OF SIDE EFFECTS
WO2008045564A2 (en) * 2006-10-12 2008-04-17 Epix Delaware, Inc. Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
JP2011506466A (ja) 2007-12-11 2011-03-03 株式会社サイトパスファインダー カルボキサミド化合物ならびにケモカイン受容体アゴニストとしてのそれらの使用
WO2010039801A2 (en) 2008-10-02 2010-04-08 The J. David Gladstone Institutes Methods of treating hepatitis c virus infection
MX2023001202A (es) 2020-07-29 2023-02-23 Amryt Pharmaceuticals Inc Lomitapida para uso en metodos para tratar la hiperlipidemia e hipercolesterolemia en pacientes pediatricos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL120013C (OSRAM) * 1958-04-14
BE620639A (OSRAM) * 1961-07-25
SE353319B (OSRAM) * 1964-08-15 1973-01-29 Sumitomo Chemical Co
DE1618959C3 (de) * 1967-10-04 1978-12-14 Sumitomo Chemical Co., Ltd., Osaka (Japan) Fettsäureamide und Verfahren zu ihrer Herstellung
DE2830351A1 (de) * 1978-07-11 1980-01-24 Consortium Elektrochem Ind Acylanilide
GR69291B (OSRAM) * 1979-06-25 1982-05-13 May & Baker Ltd
BR8106184A (pt) * 1980-01-25 1981-11-24 Reanal Finomvegyszergyar Processo para preparacao de derivados de n-aril-n'-(mono-ou dissubstituido)-ureia
US4749812A (en) * 1985-05-27 1988-06-07 Mitsui Toatsu Chemicals, Inc. N-(3-chloro-4-isopropylphenyl) carboxamide derivative and selective herbicide
MA20552A1 (fr) * 1985-10-11 1986-07-01 Pan Medica Sa Alkylacarboxamides de pyridylalkylamines,leurs preparations et leurs utilisations

Also Published As

Publication number Publication date
DK94188D0 (da) 1988-02-23
ATE89814T1 (de) 1993-06-15
ZA88604B (en) 1989-09-27
PT86811B (pt) 1992-05-29
JPS63253060A (ja) 1988-10-20
NO174043C (no) 1994-03-09
AU1135488A (en) 1988-08-25
NO174043B (no) 1993-11-29
US4716175B1 (OSRAM) 1993-06-22
EP0283742A3 (en) 1989-07-26
FI880796A0 (fi) 1988-02-19
DE3881249T2 (de) 1993-09-16
DK165406B (da) 1992-11-23
DK165406C (da) 1993-04-13
PT86811A (pt) 1988-03-01
NO880774D0 (no) 1988-02-23
HK148195A (en) 1995-09-22
KR880009933A (ko) 1988-10-05
FI880796A7 (fi) 1988-08-25
FI89593C (fi) 1993-10-25
FI89593B (fi) 1993-07-15
AU610558B2 (en) 1991-05-23
MX9203139A (es) 1992-07-01
EP0283742A2 (en) 1988-09-28
IE59998B1 (en) 1994-05-18
JPH07121895B2 (ja) 1995-12-25
DE3881249D1 (en) 1993-07-01
ES2056843T3 (es) 1994-10-16
NZ223410A (en) 1989-11-28
US4716175A (en) 1987-12-29
NO880774L (no) 1988-08-25
EP0283742B1 (en) 1993-05-26
DK94188A (da) 1988-08-25
IE880204L (en) 1988-08-24

Similar Documents

Publication Publication Date Title
CA1336913C (en) Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase
US5612377A (en) Method of inhibiting leukotriene biosynthesis
US4064125A (en) Substituted amides having antiinflammatory activity
JP2575183B2 (ja) 抗高脂血性および抗アテローム性動脈硬化性の尿素およびカルバメート化合物
JPH0133470B2 (OSRAM)
PT91580B (pt) Processo para a preparacao de compostos de nicotinamida n-substituida antidepressivos
EP0044453B1 (en) New benzisoselenazolones, process for producing the same and pharmaceutical preparations containing the same
EP0344425A2 (en) N-[[(2,6-disubstituted)phenyl]-N'- arylalkyl] ureas as antihypercholesterolemic and antiatherosclerotic agents
JPH06510030A (ja) 新規な３，５−ジ−ｔｅｒｔ−ブチル−４−　ヒドロキシフェニル誘導体、それらの製造方法および薬剤
CA1300619C (en) 1-(4-hydroxy-3,5-di-tert.-butylbenzoyl)homopiperazine, various derivatives thereof, processes for the preparation of these compounds, medicaments containing them, and their use
JPS63239259A (ja) 薬剤化合物
US4722927A (en) Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase
EP0297610A1 (en) N-[(2,6-disubstituted)phenyl]-urea and carbamate inhibitors of acyl-CoA:cholesterol acyl-transferase
US4725598A (en) Derivative of dihydroxybenzamide and a pharmaceutical composition having an anti-inflammatory activity
EP0384320A1 (en) Antihyperlipidemic and anti-atherosclerotic trisubstituted urea compounds
US4743605A (en) Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase
US5238962A (en) Benzamide derivatives
US4994465A (en) Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds
JPH03218345A (ja) Ａｃａｔ阻害剤
US5523310A (en) 1,2,3-triazole derivatives
EP0304271A2 (en) Omega-arylsulphonamidoalkanoic acids for treatment of thromboxane medited diseases
EP0252524A2 (en) Aryl- and aralkylamide- derivatives of Omega- (substituted-phenyloxy)-alkanoic acids as inhibitors of acyl-coa: cholesterol acyltransferase and pharmaceuticals containing them
US5140020A (en) Derivative of dihydroxybenzamide and a pharmaceutical composition thereof
JPH0160026B2 (OSRAM)
JPS61130279A (ja) ４，６−ジアリ−ル−テトラヒドロ−２ｈ−１，３，５−チアジアジン−２−チオン誘導体

Legal Events

Date Code Title Description
MKLA Lapsed